The present invention generally relates to novel synthetic methods, systems, kits, salts, and precursors useful in medical imaging. In some embodiments, the present invention provides compositions comprising an imaging agent precursor, which may be formed using the synthetic methods described herein. An imaging agent may be converted to an imaging agent using the methods described herein. In some cases, the imaging agent is enriched in .sup.18F. In some cases, an imaging agent including salt forms (e.g., ascorbate salt) may be used to image an area of interest in a subject, including, but not limited to, the heart, cardiovascular system, cardiac vessels, brain, and other organs.

The present invention generally relates to novel synthetic methods, systems, kits, salts, and precursors useful in medical imaging. In some embodiments, the present invention provides compositions comprising an imaging agent precursor, which may be formed using the synthetic methods described herein. An imaging agent may be converted to an imaging agent using the methods described herein. In some cases, the imaging agent is enriched in .sup.18F. In some cases, an imaging agent including salt forms (e.g., ascorbate salt) may be used to image an area of interest in a subject, including, but not limited to, the heart, cardiovascular system, cardiac vessels, brain, and other organs.

A task is to provide a non-aqueous electrolytic solution exhibiting excellent cycle capacity maintaining ratio and excellent low-temperature resistance characteristics and a non-aqueous electrolyte secondary battery using the same. An object of the present invention is to provide a non-aqueous electrolytic solution which improves the cycle capacity maintaining ratio and low-temperature resistance characteristics, and a non-aqueous electrolyte secondary battery using the non-aqueous electrolytic solution. The present invention is a non-aqueous electrolytic solution comprising an electrolyte and a non-aqueous solvent dissolving therein the electrolyte, wherein the non-aqueous electrolytic solution contains a compound represented by formula (1) (wherein X represents an organic group containing a heteroatom, Y represents a sulfur atom, a phosphorus atom, or a carbon atom, n represents an integer of 1 or 2, m represents an integer of 2 to 4, l represents an integer of 1 or 2, and Z represents an organic group having 4 to 12 carbon atoms and optionally having a heteroatom), and a non-aqueous electrolyte secondary battery comprising the non-aqueous electrolytic solution.

A task is to provide a non-aqueous electrolytic solution exhibiting excellent cycle capacity maintaining ratio and excellent low-temperature resistance characteristics and a non-aqueous electrolyte secondary battery using the same. An object of the present invention is to provide a non-aqueous electrolytic solution which improves the cycle capacity maintaining ratio and low-temperature resistance characteristics, and a non-aqueous electrolyte secondary battery using the non-aqueous electrolytic solution. The present invention is a non-aqueous electrolytic solution comprising an electrolyte and a non-aqueous solvent dissolving therein the electrolyte, wherein the non-aqueous electrolytic solution contains a compound represented by formula (1) (wherein X represents an organic group containing a heteroatom, Y represents a sulfur atom, a phosphorus atom, or a carbon atom, n represents an integer of 1 or 2, m represents an integer of 2 to 4, l represents an integer of 1 or 2, and Z represents an organic group having 4 to 12 carbon atoms and optionally having a heteroatom), and a non-aqueous electrolyte secondary battery comprising the non-aqueous electrolytic solution.

Provided are a methane-production inhibitor capable of inhibiting methane production for a long period of time, and a method for inhibiting methane production using the composition. A methane-production inhibitor composition contains one or more compounds selected from compounds represented by formula [I] as an effective ingredient, and a method for inhibiting methane production uses the composition. ##STR00001## (In formula [I], X represents an —OR.sub.1 group, a hydroxyl group, or a halogen atom, Y represents an —OR.sub.2 group or an —SO.sub.2R.sub.3 group, R.sub.1 represents a benzoyl group, R.sub.2 represents a methylsulfonyl group or a chloromethylsulfonyl group, and R.sub.3 represents a chloromethyl group or a hydroxymethyl group.)

Provided are a methane-production inhibitor capable of inhibiting methane production for a long period of time, and a method for inhibiting methane production using the composition. A methane-production inhibitor composition contains one or more compounds selected from compounds represented by formula [I] as an effective ingredient, and a method for inhibiting methane production uses the composition. ##STR00001## (In formula [I], X represents an —OR.sub.1 group, a hydroxyl group, or a halogen atom, Y represents an —OR.sub.2 group or an —SO.sub.2R.sub.3 group, R.sub.1 represents a benzoyl group, R.sub.2 represents a methylsulfonyl group or a chloromethylsulfonyl group, and R.sub.3 represents a chloromethyl group or a hydroxymethyl group.)

The present invention provides a compound represented by formula (I) [wherein L represents an oxygen atom or CH.sub.2, E represents a C2-C10 chain hydrocarbon group or the like, R.sup.1 represents a C1-C3 chain hydrocarbon group or the like, R.sup.2 represents a C1-C3 chain hydrocarbon group or the like, and n is 0, 1, 2 or 3.] or its N oxide or agriculturally acceptable salt, which is a compound that have excellent pests controlling effects.

##STR00001##

The present disclosure relates to new cannabinoid sulfonate esters and processes for their use to prepare cannabinoids. The disclosure also relates to the use of catalysts and catalytic processes for the preparation of cannabinoids from the cannabinoid sulfonate esters.

A process for preparing a compound represented by Formula [1], the process comprising a step of hydrolyzing a compound represented by Formula [2] under an acidic or basic condition, and a step of reacting a compound represented by Formula [3] with a metal acetate salt, and a step of halogenating a compound represented by Formula [4]; a process for preparing a compound represented by Formula [1] comprising a step of reacting a compound represented by Formula [3] with a metal acetate salt, and then, adding alcohol, water, or base to the reaction solution to perform reaction; a process for preparing a compound represented by Formula [1] comprising a step of reacting a compound represented by Formula [3] under a presence or absence of a base, an ionic liquid and a metal sulfate salt, in water or a mixed solvent of water and an organic solvent; a compound represented by Formula [2] or a salt of the same; and a compound represented by Formula [3] or a salt of the same.

A process for preparing a compound represented by Formula [1], the process comprising a step of hydrolyzing a compound represented by Formula [2] under an acidic or basic condition, and a step of reacting a compound represented by Formula [3] with a metal acetate salt, and a step of halogenating a compound represented by Formula [4]; a process for preparing a compound represented by Formula [1] comprising a step of reacting a compound represented by Formula [3] with a metal acetate salt, and then, adding alcohol, water, or base to the reaction solution to perform reaction; a process for preparing a compound represented by Formula [1] comprising a step of reacting a compound represented by Formula [3] under a presence or absence of a base, an ionic liquid and a metal sulfate salt, in water or a mixed solvent of water and an organic solvent; a compound represented by Formula [2] or a salt of the same; and a compound represented by Formula [3] or a salt of the same.